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The amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder
characterized by motoneurons death. Mutations in the superoxide dismutase 1 (SOD1)
protein have been identified to be related to the disease. Beyond the different altered
pathways, the mitochondrial dysfunction is one of the major features that leads to the
selective death of motoneurons in ALS. The NSC-34 cell line, overexpressing human
SOD1(G93A) mutant protein [NSC-34(G93A)], is considered an optimal in vitro model to
study ALS. Here we investigated the energy metabolism in NSC-34(G93A) cells and in
particular the effect of the mutated SOD1(G93A) protein on the mitochondrial respiratory
capacity (complexes I-IV) by high resolution respirometry (HRR) and cytofluorimetry.
We demonstrated that NSC-34(G93A) cells show a reduced mitochondrial oxidative
capacity. In particular, we found significant impairment of the complex I-linked oxidative
phosphorylation, reduced efficiency of the electron transfer system (ETS) associated
with a higher rate of dissipative respiration, and a lower membrane potential. In order to
rescue the effect of the mutated SOD1 gene on mitochondria impairment, we evaluated
the efficacy of the exosomes, isolated from adipose-derived stem cells, administrated
on the NSC-34(G93A) cells. These data show that ASCs-exosomes are able to restore
complex I activity, coupling efficiency and mitochondrial membrane potential. Our results
improve the knowledge about mitochondrial bioenergetic defects directly associated
with the SOD1(G93A) mutation, and prove the efficacy of adipose-derived stem cells
exosomes to rescue the function of mitochondria, indicating that these vesicles could
represent a valuable approach to target mitochondrial dysfunction in ALS.
Keywords: NSC-34 cell line, mitochondria, ALS, high resolution respirometry, membrane potential, exosomes,
complex I, coupling efficiency
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INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a fatal late onset
neurodegenerative disease, characterized by selective
degeneration of motoneurons. In the 90–95% of cases, the
disease is sporadic, while in the 5–10% is familial (Bonafede
and Mariotti, 2017). The first mutated gene associated with
ALS was Cu/Zn-superoxide dismutase 1 (SOD1), and several
point mutations of this gene have been reported, as the G93A.
The SOD1 protein is localized in the cytoplasm and in the
intermembrane space of mitochondria. The mutations cause
a misfolding of the protein, that aggregates and interferes
with several molecular pathways, leading to motoneuron
degeneration (Wiedau-Pazos et al., 1996; Kruman et al., 1999;
Cozzolino and Carrì, 2012). In addition, the misfolded SOD1
protein compromises mitochondrial function and induces
morphological changes, such as swelling and formation of
vacuoles in the mitochondrial matrix (Raimondi et al., 2006;
Martin et al., 2007). Mitochondria are involved in energy
production (ATP), cellular respiration, calcium homeostasis
and are responsible for the production of reactive oxygen
species (ROS). Alterations of mitochondria regarding their
ultrastructure, morphology and the dysfunction of elements
of the electron transfer system (ETS) have been reported in
motoneurons, muscles, post-mortem brain tissue, lymphocytes,
and liver of ALS murine models and patients (Nakano et al.,
1987; Bowling et al., 1993; Curti et al., 1996; Wiedemann et al.,
1998; Vijayvergiya et al., 2005).
The mitochondrial defects associated with ALS have been
studied on isolated enzymes or purified mitochondria (Mattiazzi
et al., 2002; Menzies et al., 2002). In ALS patient’s lymphocytes,
enzymatic assays on NADH-ferricyanide reductase showed
a reduction of complex I activity compared to controls
(Ghiasi et al., 2012). In patient fibroblasts, the evaluation
of mitochondrial function revealed a specific deficit in ALS
patients compared to control groups (Walczak et al., 2019).
In isolated coupled mitochondria obtained from SOD1(G93A)
mice tissues (brain, liver, and spinal cord) at disease onset, a
reduced complex I-linked phosphorylative activity (sustained
by glutamate and malate) was reported (Mattiazzi et al.,
2002). A recent systematic review points out an early and
lasting reduction of complex I activity and respiratory rates
alterations in transgenic SOD1(G93A) mice, compared to wild-
type (Irvin et al., 2015). In primary SOD1(G93A) motoneurons,
lower mitochondrial membrane potential and impairment of
calcium homeostasis were found compared to controls (Kruman
et al., 1999). Specific silencing of the SOD1(G93A) tans-gene
significantly delays the onset of the disease and improves
the life-span of these mice (Xia et al., 2006). These studies
indicated that the mitochondrial alterations found in ALS
patients occur also in vitro and in vivo ALS models, supporting
their use to test possible new therapeutic approaches acting on
mitochondrial dysfunction.
A novel therapeutic strategy proposed for neurodegenerative
disease concerns the use of exosomes derived from stem cells.
Exosomes are extracellular vesicles released from all cell types
and are able to recapitulate the efficacy of the origin cells. To this
purpose, exosomes isolated from stem cells are used as a possible
therapy in different neurodegenerative diseases, instead of using
the parental cells and avoiding the possible consequences of cell
therapy (Bonafede and Mariotti, 2017). We recently reported
that exosomes isolated from adipose-derived stem cells (ASCs,
ASCs-exosomes) are neuroprotective inhibiting apoptosis in an
in vitro ALS model, the motoneuron-like cell line (NSC-34)
(Bonafede et al., 2016). Since mitochondria are involved in the
cellular apoptotic pathways through the release of cytochrome c,
their dysfunction may exacerbate the susceptibility and death
of motoneurons in ALS (Kruman et al., 1999). Moreover, it
has been reported that the treatment of primary neuronal
cells with ASCs-exosomes, alleviate the aggregation of SOD1
mutated protein and normalize the phospho-CREB/CREB ratio
and PGC-1α expression level (Lee et al., 2016). However, the
specific action of ASCs-exosomes on mitochondrial respiratory
pathways remains to be clarified.
In this study, we used the murine NSC-34 cell line since they
express the typical physiological and morphological properties of
motoneurons. Moreover, to mimic the motoneuron phenotype
in ALS, they were stably transfected with the human mutant
SOD1(G93A) gene (Bonafede et al., 2016). We investigated the
alterations of mitochondrial function concerning the relative
contributions of mitochondrial complexes and the coupling
efficiency in the in vitro model of ALS. To this purpose, we used
the high resolution respirometry (HRR), a technique that allows
studying mitochondrial respiratory capacity (complexes I-IV),
integrity and energy metabolism in intact or permeabilized cells.
The intact cells were analyzed in cell culture media, ensuring
availability of substrates and appropriate ionic composition to
maintain the cell membrane potential and intact signaling.
In this condition, mitochondrial activity is related to the
use of endogenous substrates (Pesta and Gnaiger, 2012). On
the other hand, the use of permeabilized cells, that allows
adding specific substrates, is necessary to investigate the role
of each mitochondrial complex (Pesta and Gnaiger, 2012), and
to analyze the mitochondrial respiratory profile in different
respiratory states (ROUTINE, LEAK, OXPHOS, and ETS), as
reported by Gnaiger et al. (2019).
In the present study, we demonstrated that the expression
of the mutated protein SOD1(G93A) induces mitochondrial
dysfunction, interfering with oxidative phosphorylation
mediated by complex I and reducing the coupling efficiency
and the mitochondrial membrane potential. Moreover, we
provide evidence that ASCs-exosomes are able to revert the
mitochondrial dysfunction induced by mutant SOD1(G93A)
protein in NSC-34 cells, adding new insights to their
neuroprotective action and endorsing the idea that these




The plasmids pcDNA3-SOD1(WT) and pcDNA3-SOD1(G93A)
were purchased from Addgene (Cambridge, United States) and
used as template to amplify by PCR the respective cDNA.
Briefly, hSOD1 cDNAs were amplified with AccuPrime DNA
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polymerase (Invitrogen) and cloned in Sgf I and MluI sites of
pCMV6-AN-His-HA plasmid (OriGene) to generate a vector,
expressing the human SOD1 gene tagged at the N-terminus with
polyhistidine (His) tag and HA. For lentiviruses preparation,
the His-HA tagged genes were excised from pCMV6-HIS-HA
plasmids and subcloned into the BamHI and XhoI sites of
the vector pENTR1A (w48-1, Addgene). The resulting vectors
were then recombined with pLenti CMV/TO Puro DEST (670-
1, Addgene) using Gateway LR-Clonase (Life Technologies)
to get the lentiviral vectors expressing hSODWT and its
mutant under the control of a doxycycline-inducible promoter.
Lentiviruses were then prepared in accordance with the protocols
detailed by Campeau et al. (2009), meeting Biosafety Level 2
(BSL-2) requirements.
Transduction and Generation of
Inducible Cell Lines
The murine NSC-34 motoneuron-like cell line was purchased
from CELLutions Biosystem Inc. (Ontario, Canada). To
establish an inducible cell line, NSC-34 cells were primarily
transduced with the pLentiCMV_TetR_Blast vector (Addgene),
constitutively expressing the tetracycline (Tet) repressor under
the control of a CMV promoter, and selected for 7 days using
10 µg/ml Blasticidin (Sigma-Aldrich). The stable cells were
infected with the lentiviral vectors expressing hSOD1(WT) or
hSOD1(G93A) genes in the presence of 4 µg/ml polybrene and
selected by using 5 µg/ml puromycin. The overexpression of
transgenes was induced with 5 µg/ml doxycycline (Clontech) for
24 h in culture.
Cells Culture
We used NSC-34 naïve cells, NSC-34 cells stably transfected
with the human wild type SOD1 gene, NSC-34 SOD1(WT),
or the mutated SOD1(G93A) gene, NSC-34 SOD1(G93A). The
SOD1 gene expression is under the control of a DOXYcycline-
inducible promoter (Bonafede et al., 2016). Cells were cultured
using DMEM with 10% FBS, 100 U/ml penicillin and 100 µg/ml
streptomycin (all from GIBCO LifeTechnologies, Milan, Italy).
The cultures were incubated at 37◦C/5% CO2. For the
experiments, cells (1 × 106) at the 7–9 passages were used. All
the experiments were performed in triplicate.
The NSC-34 naïve cells were seeded in the culture medium
and after 24 h the cells were harvested, pelleted by centrifugation
and re-suspended in warm DMEM.
The NSC-34 SOD1(WT) and NSC-34 SOD1(G93A) cells were
seeded and, after 1 day, 5 µg/ml of doxycycline (Doxycycline,
Clontech) (DOXY+) was added to the culture medium for 24 h
to induce the expression of the human SOD1 genes. In the text,
these cells will be called WTDOXY+ and G93ADOXY+. The
absence of doxycycline in the culture medium (DOXY−) is used
as a negative control (WTDOXY− and G93ADOXY−). After
the induction, we harvested the cells, pelleted by centrifugation
and re-suspended in 37◦C DMEM for intact cells or MIR05
(0.5 mM EGTA, 3 mM MgCl2·6H2O, 60 mM K-lactobionate,
20 mM taurine, 10 mM KH2PO4 20 mM Hepes, 110 mM
sucrose, and 1 mg/ml bovine serum albumin, pH 7.1 at 30◦C) for
permeabilized cells.
The adipose-derived stem cells were used to isolate
exosomes. Cells were isolated from inguinal adipose tissues
of 8/12 week-old C57BL/6 mice (Charles River, Italy), as
previously described (Bonafede et al., 2016). Briefly, the
inguinal fat was incubated in Hank’s Balanced Salt Solution
(HBSS, Life Technologies) with collagenase type I (Life
Technologies) and bovine serum albumin (BSA, AppliChem).
Centrifugation was performed to obtain a stromal vascular
fraction, that was resuspended in NH4Cl, centrifuged and
filtered through a 40-µm nylon mesh to remove cellular debris.
Cells were cultured using DMEM with 10% FBS, 100 U/ml
penicillin and100 µg/ml streptomycin. The ASCs cultures were
incubated at 37◦C/5% CO2. Murine ASCs were carachterized by
immunophenotype using monoclonal antibodies, as previously
described (Bonafede et al., 2016).
Western Blot of NSC-34 Cells
The NSC-34 naïve, WTDOXY+, G93ADOXY+, and
G93ADOXY− cells were lysed for 20 min at 4◦C in RIPA buffer
supplemented with protease inhibitors (Thermo Fisher Scientific
Pierce) and proteins concentration was determined using a
Bradford assay (Sigma). Denatured samples, obtained by boiling
at 95◦C in Laemmli SDS-sample buffer, were separated by 12%
SDS-polyacrylamide gel electrophoresis, and electro transferred
on nitrocellulose membrane. The membranes were blocked for
1 h at room temperature in TBST buffer (10 mM Tris–HCl,
100 mM NaCl, 0.1% (v/v) Tween 20, pH 7.5) containing 5%
milk, followed by overnight incubation at 4◦C with primary
antibodies: anti-SOD1 (α-SOD) (Novus Biologicals, Littleton,
CO, United States, 1:1000), anti-hemoagglutinin (α-HA) (Bethyl
Laboratories, 1:1000) to recognize the HA epitope expressed
by the human SOD1(G93A) and SOD(WT) lentiviral vector
and anti-α-tubulin (Santa Cruz Biotechnology, Santa Cruz,
CA, United States, 1:5000) was used as housekeeping gene. The
membranes were processed with Pierce ECL Plus from Thermo
Fisher Scientific (Rockford, IL, United States).
ASCs-Exosomes Isolation and NSC-34
Treatment
Exosomes were isolated from the culture medium of 8 × 106
ASCs. The cells were cultured to confluence and, to avoid
any contamination of shed membrane fragments and vesicles
from serum, 48 h of FBS deprivation was performed. Cell
culture supernatants were then collected and PureExo Exosome
isolation kit (101Bio, CA, United States) was used for exosomes
isolation, following the manufacturer’s protocol. Exosomes were
resuspended in 100 µl of PBS and used directly or stored at
−80◦C. The determination of the protein content of exosomes
was performed by Bicinchoninic Protein Assay (BCA method)
using the manufacturer’s protocol (Thermo Fisher ScientificTM
PierceTM BCATM Protein Assay).
The treatment with ASCs-exosomes was performed on
G93ADOXY+ cells. The cells were seeded and incubated for 3 h
with or without ASCs-exosomes (EXO) at a final concentration of
0.2 µg/ml in the culture medium. Control cells were treated with
the same amount of PBS.
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ASCs-Exosomes Characterization:
Electron Microscopy and Western Blot
Analysis
Exosomes were fixed in 2% glutaraldehyde in DNase/RNase-
Free Distilled Water (for 10 min on 150 mesh formvar and
carbon-coated copper grids (Società Italiana Chinici, Rome,
Italy), and dried under a hood. The images were acquired
with a transmission electron microscopy (TEM) using a
Morgagni 268D electron microscope (Philips, Andover, MA,
United States) operating at 80 kV and equipped with a Megaview
II camera (Olympus corporation, Tokyo, Japan) for digital
image acquisition.
To perform Western blot of ASCs-exosomes, the proteins
were denatured, separated on 4-12% polyacrylamide gels,
transferred onto a nitrocellulose membrane and probed with
antibodies against Alix (1:50, Santa Cruz Biotechnology,
Q-19:sc-49268), heat shock protein 70 (HSP70, 1:100 Santa Cruz
Biotechnology, sc-1060), and tetraspanine CD81 (1:100 Santa
Cruz Biotechnology, sc-9158). The appropriate HRP-conjugated
secondary antibodies against primary antibody (all secondary
antibodies from Dako Agilent) were used. ASCs lysates were
used as positive control. The blots were then incubated with a
chemiluminescent HRP substrate and detected with G:BOX F3
GeneSys (Syngene, United Kingdom).
High Resolution Respirometry
We used Oxygraph-2K (Oroboros Instruments, Innsbruck)
to analyze mitochondrial respiratory capacity (complexes
I-IV) in the NSC-34 naïve, WTDOXY+, WTDOXY−,
G93ADOXY+, and G93ADOXY− cell lines. In particular,
protocols for intact and permeabilized cells were used to evaluate
cellular oxygen consumption (Pesta and Gnaiger, 2012). The
oxygen respiratory flux was expressed per million cells or flux
control ratio (FCR) relative to the maximal uncoupled ETS
capacity. Instrumental and chemical background fluxes were
opportunely calibrated as a function of oxygen concentration
using DatLab software (Oroboros Instruments). The HRR
was used to determine the rate of oxygen consumption
in the various respiratory states: ROUTINE and LEAK
respiration, uncoupled maximal ETS capacity and ROX
(residual oxygen consumption). The ROUTINE state respiration
is recorded in physiological coupling condition and depends
on cellular energy demands, the LEAK respiration is the
oxygen consumption associated with dissipative processes
compensating for proton and electron leak and cations
cycling. The ETS capacity is the maximal oxygen consumption
measured at the optimal uncoupler (Carbonyl Cyanide
3-Chlorophenylhydrazone, CCCP) concentration that dissipates
the electrochemical proton gradient. After the inhibition
of the ETS machinery, oxygen consumption in the ROX
state was recorded.
Intact Cells
Respiration of intact cells was measured applying a coupling
control protocol (Pesta and Gnaiger, 2012) After stabilization
of ROUTINE respiration with addition of pyruvate and malate
(5 mM and 2 mM, respectively; Sigma Aldrich), the ATP-synthase
inhibitor oligomycin (Omy, 2.5 µM; Sigma Aldrich) was added
to obtain a measure of LEAK respiration, followed by titration of
CCCP (0.5 µM steps; Sigma Aldrich) to evaluate the maximum
oxygen flux (ETS). Finally, Rotenone (Rot) and Antimycin A
(Ama) (2 and 2.5 µM, respectively; Sigma Aldrich) were added
to inhibit complex I and III, respectively, in order to obtain ROX.
Permeabilized Cells
The respiration of permeabilized cells was determined using
substrate-uncoupler-inhibitor titration (SUIT) modified
protocols (Pesta and Gnaiger, 2012). To investigate the
contribution of different mitochondrial complexes (I-IV) to
respiratory capacity, cells were permeabilized with the mild
detergent digitonin (16 µM, Sigma Aldrich). This concentration
was evaluated in preliminary experiments as suitable to achieve
full permeabilization of cells allowing the access of substrates
and ADP to mitochondria without compromising mitochondrial
function. Pyruvate, Malate (PM; 5 mM and 2 mM, respectively)
and successively Glutamate (G; 10mM), were used to determine
complex I activity (PMG). The ADP (5mM, Sigma Aldrich)
was added to stimulate the OXPHOS capacity. To activate
the complex II, the succinate was added (S; 10 mM, Sigma
Aldrich). The presence of all these substrates (PMGS) allows
detecting the respiratory activity of linked complexes I and II.
The contribution of complexes III and IV to respiratory activity
is always present, although they were not stimulated by the
addition of specific substrates.
To analyze the ETS capacity, steps titrations with the
uncoupler CCCP (0.5 µM steps; Sigma Aldrich) were performed.
Rot and Ama (2 and 2.5 µM, respectively; Sigma Aldrich) were
added to inhibit complex I and III determining ROX.
Mitochondrial Membrane Potential
The mitochondrial transmembrane potential was measured
by cytofluorimetry, using the fluorescent dye 3,3′-
dihexyloxacarbocyanine iodide [DiOC6(3), Sigma Aldrich].
DiOC6(3) is a green fluorescent membrane dye that has been
used to detect mitochondrial membrane potential in live cells.
The fluorescence of the dye is enhanced when incorporated
into mitochondrial membranes. Changes in mitochondrial
membrane potential were assessed in cells by measuring
fluorescence intensity due to a conformational change of the
dye. The G93ADOXY− cells, G93ADOXY+, and G93ADOXY+
treated with exosomes (1 × 106) were processed as described
above. Cells were resuspended in PBS containing DiOC6(3)
(1 nM), incubated at 37◦C for 15 min, immediately analyzed by
flow cytometry with a FACSCanto II (BD) and analyzed with
FlowJo software (Treestar Inc.).
Statistics
Statistical analyses were performed with GraphPad Prism
software. Student’s t-test, one-way ANOVA (Tukey correction for
multiple testing) and two-way ANOVA (Holm-Sidak correction)
were used to compare the means. For each experiment, the
statistical analysis used is reported in the figure legends. For
all analysis, significance differences are indicated as ∗p < 0.05,
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∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. Data are presented as
mean with standard deviation.
RESULTS
Mitochondrial Bioenergetics of Intact
Naïve NSC-34 Cells
In order to evaluate the effect of the mutant SOD1 protein
on mitochondrial function, we analyzed the mitochondrial
activity profile in terms of oxygen consumption and flux
control ratios in intact naïve NSC-34 cells (Figure 1). We
measured ROUTINE, LEAK, ETS, and ETS sustained by
complex II ETS(cII) respiratory states in NSC-34 cells, a
condition in which mitochondria exploit intracellular available
substrates (Figure 1A). The graph in Figure 1B shows
data of oxygen consumption recorded in these respiratory
states in the cells. The ROUTINE state, that is relative to
unstimulated endogenous oxygen consumption, has a value of
27 ± 5.5 pmol∗sec−1/106cells. The flux control ratios, obtained
by normalizing the oxygen consumption data of each respiratory
states to the ETS (that represents the maximal uncoupled
oxygen consumption), shows an oxygen consumption in the
ROUTINE equal to 57%, and 14% in the LEAK respiratory
states (Figure 1C). These data characterize the mitochondrial
bioenergetics profile of the intact naïve NSC-34 cells, necessary to
study the effect of the G93A point mutation in the SOD1 protein.
Expression of the Human SOD1 Protein
in NSC-34 Transfected Cells
To evaluate the impact of the mutant SOD1 protein on
mitochondrial bioenergetics, we confirmed the expression of
the human proteins (WT or G93A) in the NSC-34 cells. As
expected, we detected endogenous murine SOD1 protein in all
cell types and the human SOD1 protein (with the HA-tag) only in
WTDOXY+ and G93ADOXY+ cells (Figure 2A).
Mitochondrial Bioenergetics of Intact
NSC-34 Transfected Cells
We analyzed mitochondrial respiratory capacity (complexes
I-IV) on WTDOXY+, WTDOXY−, G93ADOXY+, and
G93ADOXY− cells. We found that WTDOXY− show the
FIGURE 1 | Oxygen consumption and flux control ratios of the naïve NSC-34 intact cells obtained by high resolution respirometry. (A) Rate of oxygen consumption
of intact naïve NSC-34 measured at 37◦C in DMEM in the following states: the ROUTINE respiration sustained by pyruvate, malate, and endogenous substrates; the
LEAK respiration obtained following addition of olygomicin; the maximal uncoupled ETS capacity (addition of CCCP) and the ROX, residual oxygen consumption
following addition of the inhibitor of complex III antimycin A. The red line represent the rate of oxygen consumption normalized per number of cells. (B) Quantitative
analysis of data of oxygen consumption in the different respiratory states. (C) Flux control ratios, data normalized to the ETS. Data in (B,C) are represented as
mean ± SD, n = 7.
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FIGURE 2 | The expression of the human mutant SOD1(G93A) in NSC-34
cells impairs mitochondrial function. (A) Representative Western blot assay
performed on cells lysates of WTDOXY–, G93ADOXY–, G93ADOXY+, and
WTDOXY+ cells. Endogenous mouse SOD1 (mSOD1) immunoreactivity was
detected in all samples with anti-SOD1 antibody (left panel), whereas
HA-tagged human SOD1 (hSOD1) was detected only in (DOXY+) samples
following incubation for 24 h with doxycycline (right panel), n = 3.
(B) Mitochondrial flux control ratios of naïve, WTDOXY+, G93ADOXY–, and
G93ADOXY+ intact cells in the LEAK state relative to maximal ETS capacity.
(C) ETS coupling efficiency of naïve, WTDOXY+, G93ADOXY–, and
G93ADOXY+ intact cells determined as 1-(L/E). One-way ANOVA analysis;
∗p < 0.05, ∗∗p < 0.01. Data are represented as mean ± SD, n = 4.
same mitochondrial bioenergetics profile of WTDOXY+ cells
(data not shown). The mitochondrial function of G93ADOXY+
was compared to the G93ADOXY−, WTDOXY+, and naïve
cells. The analysis of the flux control ratios reveals significant
differences between groups for the LEAK values [F(3,12) = 13.29
p = 0.0004, n = 4]. Indeed G93ADOXY+ cells show a significant
increase in the LEAK compared to G93ADOXY− (p = 0.001),
to WTDOXY+ (p = 0.01), and to naïve cells (p = 0.03)
(Figure 2B). Consistently, the expression of human SOD1
mutated protein significantly affects the ETS coupling efficiency
(1-L/E), which is reduced in G93ADOXY+ cells compared to
G93ADOXY− (–17%, p = 0.02) to WTDOXY+ (–15%,
p = 0.01), and to naïve cells (–10%, p = 0.03) (Figure 2C).
LEAK relative to ETS and ETS coupling efficiency did
not show other significant differences between the naïve,
WTDOXY+ and G93ADOXY− cells (Figures 2B,C). The
results demonstrate that the expression of mutated human
SOD1 protein impairs metabolic efficiency in mitochondria
of intact cells.
The FCR in the LEAK and the ETS coupling efficiency
of WTDOXY+ cells are not significantly different compared
to naïve cells, indicating that the induction with doxycycline
does not affect the mitochondria. Moreover, the expression
of human WT SOD1 protein is not responsible for the
mitochondrial bioenergetics alteration (Figure 2). These data
demonstrate that the mitochondrial dysfunction is related to the
SOD1(G93A) expression.
Mitochondrial Bioenergetics of
Permeabilized NSC-34 SOD1(G93A) Cells
To investigate the role of SOD1(G93A) in the alteration
of mitochondrial complexes, we permeabilized the plasma
membrane allowing specific substrates and inhibitor molecules
to enter in the cells. The Figure 3A shows a representative rate
of oxygen consumption in the respiratory states (ROUTINE,
LEAK, OXPHOS, and ETS) analyzed in G93ADOXY− cells. The
digitonin, that allows to permeabilize the cells, was added at
the end of ROUTINE state. The addition of pyruvate, malate
(PM), and glutamate (PMG) stimulates the complex I and
allow to evaluate its function. The ADP was added at the end
of the LEAK state to stimulate the oxidative phosphorylation
(OXPHOS). The further addition of succinate (PMGS) stimulates
also complex II to assess the synergistic contribution of complex
I and complex II. The CCCP was added to induce the ETS
state, the rotenone inhibiting the complex I allows to measure
the contribution of complex II. Finally, the evaluation of
ROX was obtained by adding the inhibitor of complex III
antimycin A (Figure 3A).
The comparison of oxygen consumption levels between
G93ADOXY− and G93ADOXY+ cells in the analyzed
respiratory states showed significant differences [F(1,48) = 78.77
p < 0.0001, n = 9]. The oxygen consumption of complex I
(PMG) in the OXPHOS is significantly reduced in G93ADOXY+
cells compared to G93ADOXY− (–27%, p < 0.0004). In
G93ADOXY+ cells, the oxygen consumption remains at lower
levels compared to G93ADOXY− (–22%, p < 0.0001) even after
stimulation of complex II (PMGS) (Figure 3B). In the OXPHOS,
the relative contribution of the complex I and complex II in
G93ADOXY− is about 50% each, while in G93ADOXY+ cells
the contribute is 45% and 55%, respectively.
Moreover, the oxygen consumption of G93ADOXY+ cells in
the ETS state (PMGS) was reduced (–22%, p < 0.0001), compared
to G93ADOXY−. The contribution of the complex II in the
ETS (S) is significantly decreased (–15%, p = 0.01) compared to
G93ADOXY− (Figure 3B). These data suggest that the oxygen
consumption linked to OXPHOS and ETS respiratory states is
significantly reduced in G93ADOXY+ cells.
To evaluate the relative contribution of the various
complexes to mitochondrial respiration we analyzed the
flux control ratios (Figures 3C–E and Supplementary Table S1).
The G93ADOXY+ cells showed an increase in the LEAK
compared to G93ADOXY− (+14%, p = 0.04, Figure 3C),
indicating that ETS is dissipative and highlighting a possible
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FIGURE 3 | Mitochondrial complexes contribution to oxidative phosphorylation in permeabilized G93ADOXY+ and G93ADOXY– cells. (A) Rate of oxygen
consumption (red line) of permeabilized G93ADOXY– cells measured at 37◦C in Mir05 in the following states: the ROUTINE respiration sustained by pyruvate and
malate (PM) and endogenous substrates; the LEAK respiration evaluated following permeabilization with digitonin; the ADP addition stimulated OXHPOS capacity
sustained by complex I (pyruvate, malate and glutamate, PMG) and complex II (pyruvate, malate, glutamate and succinate, PMGS); the maximal uncoupled ETS
capacity (addition of CCCP); ETS sustained by complex II following inhibition of complex I by rotenone; the ROX, residual oxygen consumption, following addition of
the inhibitor of complex III antimycin A. (B–E) Dot plots corresponding to respirometry experiments, showing data from all samples. Each dot corresponds to one
sample. The line shows the mean with standard deviation. Paired samples are represented by symbols of the same color. (B) Quantitative analysis of the rate of
oxygen consumption of G93ADOXY– and G93ADOXY+ permeabilized cells: the values relative to ROUTINE, LEAK, OXPHOS, and ETS for paired samples are
reported. (C–E) Flux control ratios, normalized to the maximal uncoupled ETS capacity, of G93ADOXY–, and G93ADOXY+ permeabilized cells in the LEAK, OXPHOS
and ETS(cII) respiratory states. Data are represented as percentage of control (G93ADOXY– cells). Data of flux control ratios (mean ± SD) in G93ADOXY– cells are:
(C) LEAK (0.28 ± 0.03), (D) OXPHOS(PMG) (0.50 ± 0.04), and (E) ETS(cII) (0.69 ± 0.05). Analysis of G93ADOXY– vs. G93ADOXY+ cells at various respiratory states
was performed using two-way ANOVA (Holm-sidak’s post hoc correction) ∗p < 0.05, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001 (B); paired student T test (C–E) ∗p < 0.05.
n = 9.
alteration of the quality of inner mitochondrial membrane.
Moreover, in G93ADOXY+ cells, a decrease of the flux
control ratio in the OXPHOS sustained by complex I (PMG)
was detected compared to G93ADOXY− (–10%, p = 0.03,
Figure 3D), reinforcing the idea that the complex I is mainly
affected. The contribution of complex II to ETS capacity is
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increased in G93ADOXY+ cells compared to G93ADOXY−
(+7%, p = 0.04, Figure 3E), suggesting a compensatory
activity of complex II.
Altogether, these data confirm that the human SOD1
mutant protein is involved in mitochondrial dysfunction and
demonstrate that the mutated protein affects the coupling
efficiency and impairs the functionality of complex I.
Isolation and Characterization of
ASCs-Exosomes
After ASCs-exosomes isolation, their protein concentration was
quantified. The yield for each isolation was about 200 µg/ml
of protein. Ultrastructural analysis of the exosomes sample by
TEM shows the extracellular vesicles with the lipid bilayer,
with a diameter ranging from 30 to 120 nm (Figure 4A).
Western blot analysis reveals specific exosomal markers of
the vesicles, as Alix (90 kDa), HSP70 (70 kDa), and CD81
(26 kDa) (Figure 4B). These results (size, morphology and
specific markers) demonstrate that the isolated extracellular
vesicles are ASCs-exosomes.
FIGURE 4 | TEM and Western blot analysis of ASCs-exosomes. (A) Electron
microscopy shows vesicles with characteristic morphology and size of
exosomes. Scale bar, 200 nm. (B) The blots show Western blot detection of
the expression of Alix (90 kDa), CD81 (26 kDa), and HSP70 (70 kDa) in
exosomes (EXO); ASCs lysates were used as positive control.
Exosomes Rescue Mitochondrial
Function in NSC-34 SOD1(G93A) Cells
In order to assess the potential rescue effect of ASCs-exosomes
on mitochondrial dysfunction in G93ADOXY+, these cells were
treated with ASCs-exosomes or vehicle (PBS) (Figure 5 and
Supplementary Table S2). In intact treated G93ADOXY+ cells,
data of ETS coupling efficiency showed an increase of 25%
(p = 0.005) compared to control (Figure 5A). Furthermore,
in permeabilized cells treated with exosomes, we observed a
significant increase of 14% (p = 0.04) of flux control ratio
sustained by complex I (PMG) in the OXPHOS compared to
control cells (Figure 5B). This data indicates that ASCs-exosomes
treatment leads to a partial recovery of complex I activity. The
flux control ratio sustained by both complex I and II (PMGS) in
the OXPHOS is significantly increased (p = 0.001) by exosomes
treatment in permeabilized G93ADOXY+ cells (Figure 5C).
Together, these data indicate that the incubation with ASCs-
exosomes produced an evident restoration of mitochondrial
function detected by HRR.
In addition, to evaluate if the SOD1(G93A) protein affects
the mitochondrial membrane potential, we performed the
cytofluorimetry using the DiOC6(3) probe, a dye that is
transported into the mitochondria by the negative mitochondrial
membrane potential and thus concentrates within the
mitochondrial matrix (Figures 6A,B). An alteration of the
mitochondrial membrane potential implies a reduction in
the dye fluorescence intensity (Figure 6C). Data obtained by
cytofluorimetry showed significant changes between groups
[F(1.684, 13.47) = 9.058 p = 0.0043, n = 9] that the median
fluorescence intensity in G93ADOXY+ cells is reduced by
20% (p = 0.007) compared to G93ADOXY− control cells
(Figure 6D), indicating that the G93A mutation interferes
with the mitochondrial membrane potential and supporting
the reduction in ETS coupling efficiency reported above.
Consistently, the ASCs-exosomes treatment of G93ADOXY+
restored the mitochondrial membrane potential to values similar
to the control condition (G93ADOXY−), with an increase of
16% of median fluorescence intensity (p = 0.02) compared to the
untreated G93ADOXY+ cells (Figure 6D).
These results highlight that ASCs-exosomes treatment rescues
the mitochondrial dysfunction and the mitochondrial membrane
potential, demonstrating a possible therapeutic use of these
vesicles in diseases featured by mitochondrial alterations, as ALS.
DISCUSSION
In amyotrophic lateral sclerosis, mitochondrial dysfunction has
been proposed to play a key role in the selective vulnerability of
motoneurons (Cozzolino and Carrì, 2012). It has been reported
histopathological and functional mitochondrial alterations in
both ALS murine models and patients (Jung et al., 2002; Dupuis
et al., 2003; Higgins et al., 2003; Sasaki and Iwata, 2007).
It has been demonstrated that misfolded mutated SOD1
proteins aggregate, leading to an imbalance between ROS
production and removal, causing net ROS accumulation
(Golpich et al., 2017). The increase of oxidative stress
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FIGURE 5 | Mitochondrial function in G93ADOXY+ cells after exosomes treatment. Dot plots of data obtained from respirometry experiments, showing the effects of
vehicle (PBS), or exosomes (EXO) treatment in DOXY+ cells for all samples. Each dot corresponds to one sample. The line shows the mean with standard deviation.
Paired samples are represented by symbols of the same color. (A) ETS coupling efficiency in G93ADOXY+ intact cells following treatment with exosomes (EXO) or
PBS. (B) Flux control ratio of the OXPHOS sustained by complex I (PMG) in G93ADOXY+ permeabilized cells following incubation with exosomes (EXO) or PBS.
(C) Flux control ratio of the OXPHOS sustained by complex II (PMGS) in G93ADOXY+ permeabilized cells following incubation with exosomes (EXO) or PBS.
Comparison of EXO vs. PBS treated G93ADOXY+ cells was performed using paired t-test. Data are represented as percentage of control (PBS). Data of flux control
ratios (mean ± SD) in PBS treated cells cells are: (A) ETS coupling efficiency (0.54 ± 0.13), (B) OXPHOS(PMG) (0.29 ± 0.07), and (C) OXPHOS(PMGS)
(0.81 ± 0.12). Paired T test ∗p < 0.05, ∗∗p < 0.01. n = 7.
damages lipids, proteins and carbohydrates of mitochondrial
membranes (Golpich et al., 2017). Indeed, morphological analysis
of mitochondria of NSC-34 SOD1(G93A) revealed altered
membranes, characterized by abnormal cristae (Raimondi et al.,
2006). Alterations of mitochondria, associated with reduced
mitochondrial membrane potential, have been reported also
in mutated human SOD1(G37R) neuroblastoma cells and in
SOD1(G93A) primary motoneurons (Kruman et al., 1999;
Coussee et al., 2011). A recent meta-analysis shows that in SOD1
transgenic mice the level of ATP production is reduced from the
pre-clinical stage (Irvin et al., 2015).
Concerning the study on alterations of mitochondria
functionality, the activity of respiratory complexes was evaluated
in isolated enzymes or mitochondrial preparations obtained
from bioptic samples or cell culture (Menzies et al., 2002;
Ghiasi et al., 2012). The main limitation in using isolated
mitochondria consists of the requirement of a large amount
of material (tissue or cells) and in the risk of damaging the
organelle during the isolation procedure. On the other hand,
the approach based on respirometry in living cells allows to
avoid these limitations and obtain detailed information about
mitochondrial impairment of the cellular bioenergetic state
(Djafarzadeh and Jakob, 2017a,b).
In fibroblasts obtained from ALS patients, mitochondrial
oxygen consumption was found to be reduced in cells bearing
the mutated SOD1(I113T) protein (Allen et al., 2014). Another
study reported that mitochondrial coupled respiration and
coupling efficiency was reduced in intact NSC-34 cells expressing
the G93A mutation (Richardson et al., 2013). However, these
studies were performed on intact cells, without the possibility
to clarify the contribution of single complex of the ETS to
aerobic respiration. The mitochondrial dysfunction was also
reported in NSC-34 cell line transfected with hTDP-43 gene.
Lu et al. (2012) reported that the presence of mutated TDP-
43 protein in transfected NSC-34 cells causes morphological
abnormalities, reduces complex I activity and determines a loss of
transmembrane potential. In particular NSC-34 cells, following
transfection with the mutated protein of interest, have been
used to study the pathogenic mechanisms of ALS, including
mitochondrial dysfunction (Muyderman et al., 2009).
In the present study, we described the mitochondrial function
and the contribution of single complexes to aerobic respiration
and mitochondrial coupling efficiency through high-resolution
respirometry, that allows measuring mitochondrial respiratory
capacity, the specific role of complexes I-IV and their synergic
action. With this approach, we preserve mitochondrial integrity,
and energy metabolism is evaluated in real time directly on
living cells. Moreover, the possible alteration of the mitochondrial
membrane potential was studied.
To this purpose, we used an in vitro model of ALS disease
[NSC-34 SOD1(G93A)]. We characterized the bioenergetic
profile of living NSC-34 naïve cells and the impairment of
the mitochondrial complexes associated with the mutated
SOD1 protein using the HRR. We observed an increase of
the dissipative LEAK respiration in intact G93ADOXY+
cells, accompanied by a reduction of the coupling efficiency,
compared to the other conditions. These results suggest
that the expression of the mutated SOD1 protein in these
cells leads to an alteration of mitochondrial membrane
integrity. In relation to this, results obtained with DiOC6(3)
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FIGURE 6 | Flow cytometry for mitochondrial membrane potential evaluation in G93ADOXY+ and G93ADOXY– cells. (A,B) Representative dot plots of flow
cytometry of all events collected using gates to exclude dead cells and debris (A) and to select the singlets (single cells) (B). Cell size (forward scatter, FSC) vs.
cellular granularity (side scatter, SSC) data are plotted. (C) The histograms show the intensity of DiOC6(3) probe in the G93ADOXY– cells, G93ADOXY+ cells,
and G93ADOXY+ cells treated with exosomes (EXO). (D) Measurement of mitochondrial membrane potential with DiOC6(3) probe in cells G93ADOXY– and
G93ADOXY+ following treatment with exosomes. Data are reported as median fluorescence intensity (MFI) of the probe relative to the G93ADOXY– cells. The
analysis was performed using one-way ANOVA with Tukey correction; p < 0.05. Data are represented as mean ± SD, ∗p < 0.05, ∗∗p < 0.01. n = 9.
probe showed that the SOD1(G93A) mutation affects the
mitochondrial membrane potential of NSC-34 SOD1(G93A)
cells. This observation is in line with Richardson et al.
(2013), that found a reduced coupling efficiency and a
decreased mitochondrial membrane potential in intact
NSC-34 SOD1(G93A) cells using the Seahorse instrument
and theTMRM probe.
In our study, we have investigated the contribution of
single mitochondrial complexes in the OXPHOS and ETS
respiratory states in permeabilized NSC-34 SOD1(G93A) cells,
to identify which of them are affected by SOD1(G93A) protein.
We demonstrated that the mutant SOD1 protein induces an
impairment of the complex I-linked oxidative phosphorylation.
Furthermore, in the ETS, following complex I inhibition,
we observed an increased activity indicating a compensatory
enzymatic action of complex II. The reduction of complex I
activity may be due to mitochondrial damage directly carried by
mutant SOD1 protein or to an increase of free radical species that
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reacts with complex I subunits (Yim et al., 1996; Magrane et al.,
2009; Murphy, 2009; Abeti et al., 2016).
The observed effect of SOD1(G93A) could be due to the
ability of the misfolded mutated protein to bind the VDAC1
(voltage-dependent anion channel 1), blocking the metabolite
flux across the outer mitochondrial membrane and reducing
the conductance of the channel. This phenomenon results in
reduced energy production and in an increase of oxidative stress,
contributing to mitochondrial dysfunction (Israelson et al., 2010).
It has been observed that the administration of an antioxidant
compound in a murine model of ALS counteracts the disease
progression and prolongs their lifespan (Miquel et al., 2014).
This observation suggests that the mitochondria could represent
a crucial target to cure ALS.
In addition, in SOD1(G93A) mice, a neuroprotective effect
was found following treatment with ASCs, suggesting that
the beneficial effect of the cells is mediated by extracellular
vesicles through a paracrine mechanism (Marconi et al., 2013).
This leads to the idea that these vesicles are able to mimic
the effect of parental cells suppressing the pathological
processes involved in many neurodegenerative diseases
(Biancone et al., 2012; Bonafede and Mariotti, 2017). In
light of these results, we have demonstrated a neuroprotective
effect of ASCs-exosomes in NSC-34 cell line carrying ALS
mutations, inhibiting cell death (Bonafede et al., 2016).
Moreover, exosomes released from mesenchymal stem cells
induced a neuroprotective effect on chronic experimental
autoimmune encephalomyelitis model (Farinazzo et al., 2018)
and on ischemic spinal cord by the improvement of motor
function and survival of motoneuron (Zhao et al., 2019).
This study reports that after exosomes treatment there is
an increase of superoxide dismutase activity in the spinal
cord (Zhao et al., 2019). In addition, exosomes derived
from modified ASCs were reported to be able to regulate
the autophagy and apoptosis ameliorating brain ischemia
(Huang et al., 2018).
In order to restore mitochondrial functionality in NSC-34
mutated cells, we used ASCs-exosomes. Our results show that
the ASCs-exosomes are able to restore mitochondrial function,
in terms of complex I contribution to ETS and the coupling
efficiency. Furthermore, exosomes treatment was able to restore
the mitochondrial membrane potential. One might wonder if
the exosomes are rescuing a detrimental phenotype through a
specific effect or if they act generically boosting mitochondrial
function. Although this is beyond the goal of our study, the
results point out a specific effect of exosomes on impaired
OXPHOS sustained by complex I and on ETS coupling efficiency
in NSC-34 SOD1(G93A). Nevertheless, we believe that the
effect of exosomes on other cells, such as intact naïve NSC-
34 cells, could still lead to an increased OXOPHOS sustained
by complex I but probably not in an improved ETS coupling
efficiency since the cells are not compromised by increased
oxidative stress.
Furthermore it could be interesting to compare the effects
of exosomes isolated from different sources on mitochondrial
function in this in vitro ALS model, also to identify the
peculiar mechanisms involved. Indeed we can’t exclude that also
other exosomes from different sources may affect mitochondrial
function. It has been reported that adipose-derived stem
cells exosomes and bone marrow-derived exosomes, both
of mesenchymal origin, improved mitochondrial function in
different in vitro models (Lee et al., 2016; Hogan et al.,
2019). However further studies are needed to understand the
mechanisms by which ACSs-exosomes exert their beneficial and
specific role. The presence of SOD1 protein in ASCs-exosomes
could result to be particularly interesting in ALS disease, and
in particular concerning the mitochondrial alterations related
to the disease. Indeed, some studies indicate that forms of
misfolded SOD1, deposited on the cytoplasmic surface of the
outer membrane of mitochondria in spinal cord motoneurons,
reduce the import of mitochondrial proteins and complex
I activity (Vande Velde et al., 2008; Israelson et al., 2010).
In the line of this, the presence of the SOD1 in exosomes
could counteract the mutated SOD1 protein, reducing the
mitochondrial dysfunction.
Altogether these data indicate that ASCs-exosomes could
represent a valuable approach to target mitochondrial
dysfunction in ALS, as well as in other pathologies sharing
common mitochondrial impairment.
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